David Sung Yong Kang

Founder and Clinical Director at Eyereum Ophthalmic Clinic and CEO of Eyereum Healthcare, the Republic of Korea

Kang also serves as outpatient Clinical Associate Professor at Ulsan University, Asan Medical Center and as out-patient Assistant Clinical Professor at Severance Hospital, Yonsei University School of Medicine in Seoul. His primary passion is corneal wavefront-guided ablation for amelioration of aberrations for keratoconus, cornea ectasia, and central islands. Kang has received three Best Academic Achievement Awards from the Korean Ophthalmological Society, including the Best Video Award. To date, he has rights to six patents. His first patent, registered in 2008, involves using circumlinear capsulorhexis technology during cataract surgery. Since then he has patented new methods of de-epithelization of the cornea prior to refractive surface ablation, removing phakic IOLs, and removing lenticules during SMILE.

Part of the Power List 2017

Thanks to the demographics of the developed world, the future of eyecare looks like it will be one of limited resources and rising patient burden.

So who will lead ophthalmology over the next few decades and shape its future? To find out, we asked you, our readers, to vote for ophthalmology’s Top 50 rising stars… and here they are.

Welcome to the 2017 Power List.

In 2018, The Ophthalmologist will be recognising the Top 100 pioneers and game-changers in the field of ophthalmology.

Go to The Power List 2017